logo
Plus   Neg
Share
Email

Aldeyra Therapeutics To Discontinue Noninfectious Anterior Uveitis Program

Aldeyra Therapeutics Inc. (ALDX) said that it will discontinue noninfectious Anterior Uveitis program. The statistical significance was not achieved for the primary or secondary endpoints in the noninfectious anterior uveitis SOLACE Trial, due to high rates of disease resolution in vehicle-treated patients, but activity of reproxalap was consistently greater than that of vehicle.

Meanwhile, the company said it plans to prioritize phase 3 ocular pipeline programs in dry eye disease, allergic conjunctivitis, and proliferative vitreoretinopathy.

ALDX closed Monday regular trading at $7.09, down $0.34 or 4.51 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission said it will challenge the proposed merger between two Philadelphia-area hospital systems as the deal could reduce competition, resulting in raised prices in both Philadelphia and Montgomery counties. The FTC issued an administrative complaint to block the proposed merger of Jefferson Health and Albert Einstein Healthcare Network. Step2 Co. LLC recalled about 20,500 units of Little Helper's children's grocery shopping carts for possible laceration hazard, the U.S. Consumer Product Safety Commission said in a statement. These include about 3,500 units sold in Canada. The company said the shopping cart's basket can break into sharp pieces, leading to a laceration hazard. Wendy's Co. joined the growing list of fast-food chains that are launching plant-based meat options. The fast food chain has introduced "The Plantiful," a plant-based burger, at its restaurants across Canada. Wendy's said it formulated its own recipe in-house, unlike other fast-food chains who have relied on Beyond Meat or Impossible Foods to introduce their plant-based meat alternatives.
RELATED NEWS
Follow RTT
>